|Articles|October 29, 2020
Episode 68: Rocking Garage Biotech
Author(s)Elaine Quilici
Panna Sharma, CEO of Lantern Pharma, discusses garage biotech, what he’s learned from the culture, and how it might help transform certain areas of pharma, including innovation and pricing.
Advertisement
Panna Sharma, CEO of Lantern Pharma, discusses garage biotech, what he’s learned from the culture, and how it might help transform certain areas of pharma, including innovation and pricing.
You can listen and/or download the episode on SoundCloud, or directly through iTunes, GooglePlay, Stitcher, and Overcast.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
How Does MFN Pricing Work Within TrumpRx?
2
Pharma M&A Roundup: Novartis to Acquire Excellrgy Inc., Otsuka Pharmaceutical to Acquire Transcend Therapeutics
3
Eli Lilly and Insilico Enter $2.75 Billion Research and Licensing Agreement to Advance AI Drug Discovery
4
FDA Approves Avlayah for Treatment of Hunter Syndrome
5